Derleme

Non-Surgical Treatment Options for Peyronie’s Disease

Cilt: 2 Sayı: 3 22 Eylül 2021
Damla Çınar , Sedanur Sarı , Hüseyin Alkan , Kübra Buket Ay , Enes Borcaktepe , Ahmet Yiğit Duyum , Sude Sevcan Filikçi , Eren Gençer , Çağla Senem , Serhat Soylu , Şeyma Tuna , Rabia Tuncer , Mehmet Emin Yazıcı , Emre Altıntaş , Murat Gül *
PDF İndir
EN

Non-Surgical Treatment Options for Peyronie’s Disease

Abstract

Peyronie’s disease, which occurs with the formation of a fibrous plaque in the tunica albuginea; is a disease that causes some physical problems such as bending and shortening of the penis. There are surgical treatment methods of this disease as well as non-surgical treatment methods. Non-surgical treatment methods, which are grouped under six headings: oral treatments, topical treatments, traction and vacuum treatments, shock wave therapy, intraplate injection treatments, and experimental treatments, can be preferred in cases where the symptoms are not very advanced because they provide advantages in terms of ease of application, accessibility, and cost. Although the only non-surgical treatment method approved by the FDA (U.S. Food and Drug Administration) yet is clostridium collagenase histolikum, which is used in intraplaque injection, studies have shown that other methods also reduce curvature, pain, and plaque volume.

Keywords

Peyronie’s Disease , Non-Surgical Treatment , Plaque.

Kaynakça

  1. 1. Ory J, MacDonald L, Langille G. Noninvasive Treatment Options for Peyronie’s Disease. Sex Med Rev. 2020;8(4):603-614.
  2. 2. Paulis G, Romano G, Paulis A. Prevalence, psychological impact, and risk factors of erectile dysfunction in patients with Peyronie’s disease: a retrospective analysis of 309 cases. Res Rep Urol. 2016;8:95-103.
  3. 3. Sasso F, Gulino G, Falabella R, D’Addessi A, Sacco E, D’Onofrio A et al. Peyronie’s disease: lights and shadows. Urol Int. 2007;78(1):1-9.
  4. 4. Patel DP, Christensen MB, Hotaling JM, Pastuszak AW. A review of inflammation and fibrosis: implications for the pathogenesis of Peyronie’s disease. World J Urol. 2020;38(2):253-261.
  5. 5. Armağan A, Soyupek S, Hoşcan B. Peyronie hastalığının medikal tedavisindeki yenilikler. Androloji Bülteni. 2004;6(17):93-98
  6. 6. Hussein AA, Alwaal A, Lue TF. All about Peyronie’s disease. Asian J Urol. 2015;2(2):70-78.
  7. 7. Hellstrom WJ, Bivalacqua TJ. Peyronie’s disease: etiology, medical, and surgical therapy. J Androl. 2000;21(3):347-54.
  8. 8. Mynderse LA, Monga M. Oral therapy for Peyronie’s disease. Int J Impot Res. 2002;14(5):340-4.
  9. 9. Akkus E, Yıldırım Ö. Peyronie hastalığı. In: Doğan HS, editor. Ürolojik Cerrahi Kitabı. İstanbul:Galenos; 2020. p. 289-319
  10. 10. Prieto Castro RM, Leva Vallejo ME, Regueiro Lopez JC, Anglada Curado FJ, Alvarez Kindelan J, Requena Tapia MJ. Combined treatment with vitamin E and colchicine in the early stages of Peyronie’s disease. BJU Int. 2003;91(6):522-4.

Kaynak Göster

APA
Çınar, D., Sarı, S., Alkan, H., Ay, K. B., Borcaktepe, E., Duyum, A. Y., Filikçi, S. S., Gençer, E., Senem, Ç., Soylu, S., Tuna, Ş., Tuncer, R., Yazıcı, M. E., Altıntaş, E., & Gül, M. (2021). Non-Surgical Treatment Options for Peyronie’s Disease. Archives of Current Medical Research, 2(3), 136-145. https://izlik.org/JA78HZ92TX